19th Annual International Ultmann Chicago Lymphoma Symposium


 

Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedotin, and Checkpoint Inhibitors - The Next Frontier

43 views
July 11, 2022
0 Comments
Login to view comments. Click here to Login